⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Adcock Ingram and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Adcock Ingram
↗Midrand, South Africa
Adcock Ingram is a leading South African pharmaceutical manufacturer with a history dating back to 1890. The company develops, manufactures, and distributes a wide range of healthcare products, including prescription medicines, over-the-counter (OTC) treatments, consumer health brands, and critical care hospital products.
Operating primarily in Southern Africa and India, the company is a major supplier to both the private and public sectors. It maintains several manufacturing facilities and is known for household brands such as Panado, Allergex, and Citro-Soda. In 2025, the company underwent a significant ownership shift with Natco Pharma acquiring a minority stake.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic and Branded Pharmaceuticals
SIZE & FINANCIALS
Employees:1001-5000
Revenue:ZAR 8B-9B
Founded:1890
Ownership:public
Status:operating
FUNDING
Investors:Bidvest Group, Natco Pharma
STOCK
Exchange:JSE
Ticker:AIP
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Generics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Adcock Ingram Critical Care (AICC)
Key Partnerships:Natco Pharma (Strategic shareholder)
COMPETITION
Position:Leader
Competitors:Aspen Pharmacare, Cipla
LEADERSHIP
Key Executives:
Abofele Khoele - Managing Director: Prescription
LINKS
Website:adcock.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Adcock Ingram. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.